3-Phenoxybenzoic acid (3PBA) is a key biomarker for detecting human exposure to pyrethroid insecticides, which are synthetic compounds derived from natural pyrethrins in chrysanthemum flowers. These insecticides, including permethrin, cypermethrin, and deltamethrin, are widely used in various settings and products.
When humans are exposed to pyrethroids through inhalation, ingestion, or skin contact, their bodies metabolize these compounds into 3PBA, which is excreted in urine.
Monitoring urinary 3PBA levels helps assess exposure and potential health risks, such as neurotoxicity, endocrine disruption, and developmental issues.
Pyrethroids are rapidly metabolized by cytochrome P450 enzymes into metabolites like 3PBA, which are quickly excreted in urine.
Approximately 70% of the US population has detectable levels of 3PBA, indicating widespread exposure.
Laboratory testing for 3PBA, typically using urine samples, provides a reliable measure of pyrethroid exposure, with elevated levels signaling the need for appropriate guidance and treatment.
3-Phenoxybenzoic acid (3PBA) is a metabolite that serves as a biomarker for human exposure to pyrethroid insecticides. Pyrethroid insecticides are synthetic compounds derived from natural pyrethrins found in certain chrysanthemum flowers.
These insecticides, such as permethrin, cypermethrin, deltamethrin, cyhalothrins, fenpropathrin, and trihalomethrin, are widely used in agricultural, residential, and commercial settings, as well as in pet shampoos and sprays.
When humans are exposed to pyrethroids through inhalation, ingestion, or skin contact, the body metabolizes these compounds into 3PBA, which can be detected in urine. Monitoring 3PBA levels helps assess exposure to pyrethroids and potential health risks. [2.]
Chronic or high exposure to pyrethroids can lead to adverse health effects. These may include neurotoxicity, endocrine disruption, and developmental issues. [2.] As such, the presence of 3PBA in biological samples is an important biomarker for evaluating exposure and guiding public health interventions to mitigate risks associated with pyrethroid insecticides.
When the human body metabolizes and breaks down these pyrethroid insecticides, 3PBA is formed as a result. The presence of 3PBA in urine is used as an indicator to measure and assess the extent of human exposure to these insecticides.
Exposure to high levels of pyrethroids can potentially cause neurological effects, respiratory issues, allergic reactions, and has been associated with potential developmental and hormonal effects.
Epidemiological studies have suggested that environmental exposure to pyrethroids may impair neurodevelopment, interfere with reproductive health, and increase the risk of major chronic diseases such as diabetes, cardiovascular disease (CVD), and Parkinson's disease. [2.]
Additionally, exposure to pyrethroids has been linked to both increased all-cause and cardiovascular mortality. [2.]
Ingestion, inhalation, and, to a smaller degree, dermal absorption are the primary routes of exposure to pyrethroids for the general population.
After exposure, pyrethroids are rapidly metabolized by cytochrome P450 enzymes. This metabolic process transforms pyrethroids into various metabolites.
The primary metabolites formed include:
These metabolites are readily excreted in the urine. Therefore, urinary concentrations of these metabolites are considered ideal biomarkers for assessing pyrethroid exposure.
Approximately 70% of the NHANES population had detectable levels of 3-PBA, indicating widespread exposure to pyrethroids among the general US population. [2.]
Urinary concentrations of pyrethroid metabolites are determined using high-performance liquid chromatography coupled with electrospray chemical ionization and tandem mass spectrometry.
Pyrethroids are quickly metabolized, and a large percentage is excreted as urinary 3-PBA within three days after exposure. This rapid metabolism and excretion underscore the usefulness of 3-PBA as a biomarker for recent pyrethroid exposure.
Urine samples are commonly used for 3PBA analysis due to the ease of collection and the presence of the metabolite in urine. Samples may be obtained in a clinical setting, or from the comfort of home.
It is important to consult with the ordering provider to determine if additional preparation is required prior to sample collection.
Elevated levels of 3PBA signify increased exposure to the pyrethroid family of insecticides. Care should be taken to provide appropriate guidance,counseling and treatment for symptomatic individuals with high levels of 3PBA.
Approximately 70% of the NHANES population had detectable levels of 3-PBA, indicating widespread exposure to pyrethroids among the general US population. [2.]
Low levels of 3-oxoglutaric acid are considered optimal, as they signify a reduced exposure to pyrethroid insecticides.
In addition to 3-phenoxybenzoic acid (3PBA), other biomarkers can be used to assess exposure to pyrethroid and organophosphate insecticides.
Assessment of additional metabolites of certain pyrethroid insecticides, including 3-(2,2-Dichlorovinyl)-2,2-Dimethylcyclopropane Carboxylic Acid (DCCA), 4-Fluoro-3-Phenoxybenzoic Acid (4F-PBA), and (2,2-Dibromovinyl)-2,2-Dimethylcyclopropane-1-Carboxylic Acid (DBCA) may be warranted.
These compounds can be measured in urine samples along with 3PBA to determine exposure to specific pyrethroid compounds.
Organophosphate insecticides are another class of insecticides that are commonly used.
3,5,6-trichloro-2-pyridinol (TCPy) is a metabolite of the organophosphate insecticide chlorpyrifos.
Dialkylphosphates (DAPs) are non-specific metabolites that can be formed from various organophosphate insecticides.
Testing for these biomarkers can help assess exposure to organophosphate insecticides in addition to pyrethroids.
[1.] Bao W, Liu B, Simonsen DW, Lehmler HJ. Association Between Exposure to Pyrethroid Insecticides and Risk of All-Cause and Cause-Specific Mortality in the General US Adult Population. JAMA Intern Med. 2020 Mar 1;180(3):367-374. doi: 10.1001/jamainternmed.2019.6019. PMID: 31886824; PMCID: PMC6990752.
[2.] Barr DB, Needham LL. Analytical methods for biological monitoring of exposure to pesticides: a review. Journal of Chromatography B. 2002;778(1-2):5-29. doi:https://doi.org/10.1016/s1570-0232(02)00035-1
[3.] Busby-Hjerpe AL, Campbell JA, Smith JN, Lee S, Poet TS, Barr DB, Timchalk C. Comparative pharmacokinetics of chlorpyrifos versus its major metabolites following oral administration in the rat. Toxicology. 2010 Jan 31;268(1-2):55-63. doi: 10.1016/j.tox.2009.11.022. Epub 2009 Dec 4. PMID: 19963030.
[4.] Ca.gov. Published 2024. Accessed May 29, 2024. https://biomonitoring.ca.gov/chemicals/3-phenoxybenzoic-acid-3-pba
[5.] Exposome-Explorer - 3-Phenoxybenzoic acid (PBA) (Compound). exposome-explorer.iarc.fr. Accessed May 29, 2024. http://exposome-explorer.iarc.fr/compounds/1470
[6.] Siegrist J. NMR Chemical Shifts of Impurities Charts. Merck. 2024;1(1). https://www.sigmaaldrich.com/MX/en/technical-documents/technical-article/genomics/cloning-and-expression/blue-white-screening
[7.] Wang J, Wang J, Zhu L, Xie H, Shao B, Hou X. The enzyme toxicity and genotoxicity of chlorpyrifos and its toxic metabolite TCP to zebrafish Danio rerio. Ecotoxicology. 2014 Dec;23(10):1858-69. doi: 10.1007/s10646-014-1321-8. Epub 2014 Aug 21. PMID: 25142351.